INZY
Price
$3.99
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
257.6M
64 days until earnings call
TBPH
Price
$11.25
Change
+$0.48 (+4.46%)
Updated
Jun 6 closing price
Capitalization
562.52M
63 days until earnings call
Interact to see
Advertisement

INZY vs TBPH

Header iconINZY vs TBPH Comparison
Open Charts INZY vs TBPHBanner chart's image
Inozyme Pharma
Price$3.99
Change-$0.00 (-0.00%)
Volume$451.04K
Capitalization257.6M
Theravance Biopharma
Price$11.25
Change+$0.48 (+4.46%)
Volume$295.02K
Capitalization562.52M
INZY vs TBPH Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. TBPH commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and TBPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (INZY: $3.95 vs. TBPH: $9.15)
Brand notoriety: INZY and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 243% vs. TBPH: 62%
Market capitalization -- INZY: $257.6M vs. TBPH: $562.52M
INZY [@Biotechnology] is valued at $257.6M. TBPH’s [@Biotechnology] market capitalization is $562.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both INZY and TBPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 5 TA indicator(s) are bullish while TBPH’s TA Score has 5 bullish TA indicator(s).

  • INZY’s TA Score: 5 bullish, 4 bearish.
  • TBPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, INZY is a better buy in the short-term than TBPH.

Price Growth

INZY (@Biotechnology) experienced а +0.13% price change this week, while TBPH (@Biotechnology) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

INZY is expected to report earnings on Aug 12, 2025.

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($563M) has a higher market cap than INZY($258M). INZY YTD gains are higher at: 42.780 vs. TBPH (-2.763). TBPH has higher annual earnings (EBITDA): -38.45M vs. INZY (-95.72M). INZY has more cash in the bank: 113M vs. TBPH (88.4M). INZY has less debt than TBPH: INZY (46.9M) vs TBPH (49.8M). TBPH has higher revenues than INZY: TBPH (64.4M) vs INZY (0).
INZYTBPHINZY / TBPH
Capitalization258M563M46%
EBITDA-95.72M-38.45M249%
Gain YTD42.780-2.763-1,548%
P/E RatioN/AN/A-
Revenue064.4M-
Total Cash113M88.4M128%
Total Debt46.9M49.8M94%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYTBPH
RSI
ODDS (%)
Bearish Trend 13 days ago
85%
Bullish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 13 days ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 13 days ago
82%
MACD
ODDS (%)
Bullish Trend 13 days ago
82%
Bearish Trend 13 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
87%
Bearish Trend 13 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
86%
Bearish Trend 13 days ago
71%
Advances
ODDS (%)
Bullish Trend 22 days ago
87%
Bullish Trend 21 days ago
72%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 13 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
Bullish Trend 13 days ago
79%
Aroon
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 13 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with ACAD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
N/A
ACAD - INZY
50%
Loosely correlated
-0.77%
PRME - INZY
43%
Loosely correlated
N/A
IMTX - INZY
43%
Loosely correlated
+4.26%
KROS - INZY
43%
Loosely correlated
+2.02%
AURA - INZY
38%
Loosely correlated
+0.17%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with ELEV. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then ELEV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-1.40%
ELEV - TBPH
40%
Loosely correlated
-0.98%
IMCR - TBPH
31%
Poorly correlated
-1.72%
ARCT - TBPH
31%
Poorly correlated
-1.75%
INZY - TBPH
29%
Poorly correlated
N/A
AUTL - TBPH
29%
Poorly correlated
+5.10%
More